Publication | Open Access
CRL4A-FBXW5–mediated degradation of DLC1 Rho GTPase-activating protein tumor suppressor promotes non-small cell lung cancer cell growth
62
Citations
30
References
2013
Year
Dlc1 MrnaCrl4a-fbxw5–mediated DegradationCancer BiologyTumor BiologyTranscriptional RegulationCell RegulationCancer Cell BiologyRadiation OncologyProtein DegradationCell SignalingCancer ResearchHealth SciencesDlc1 FunctionDlc1 LossCancer GeneticsEpigenetic RegulationCell BiologyLung CancerCancer GenomicsTumor SuppressorSystems BiologyMedicineCancer GrowthCell Development
Significance The DLC1 tumor suppressor gene is commonly lost in cancer by genomic deletion or epigenetic silencing, leading to loss of gene transcription. DLC1 encodes a GTPase-activating protein for the RhoA small GTPase, and DLC1 loss of expression results in aberrant RhoA activation and signaling. Unexpectedly, we found that a subset of non-small cell lung cancer patient tumors and cell lines retained DLC1 mRNA but not protein expression. We determined that the CUL4A–DDB1–FBXW5 E3 ubiquitin ligase complex is responsible for loss of DLC1 protein expression. Suppression of FBXW5 function restored DLC1-dependent lung cancer cell growth suppression. Our observations identify a mechanism for posttranslational loss of DLC1 function in cancer and substrate for CRL4A-FBXW5–driven cancer growth.
| Year | Citations | |
|---|---|---|
Page 1
Page 1